Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Faden

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Psychological Reports|September 2, 2011
Screening for attention-deficit/hyperactivity disorder in adult inpatients with psychiatric disordersGeetha Kumar, Justin Faden, Robert A Steer
Expert Opinion on Pharmacotherapy|August 15, 2023
Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorderJustin Faden, Joseph F Goldberg, Leslie Citrome
Clinical Neuropharmacology|September 15, 2015
Are Second-Generation Antipsychotics Useful in Tardive Dystonia?Narsimha Reddy Pinninti, Justin Faden, Adit Adityanjee
International Journal of Surgery Case Reports|December 4, 2012
Obesity as a defense mechanismJustin Faden, Douglas Leonard, John O'Reardon, et al.
Case Reports in Psychiatry|April 4, 2017
Delusional Disorder, Erotomanic Type, Exacerbated by Social Media UseJustin Faden, Jonathan Levin, Ronak Mistry, et al.
Expert Review of Neurotherapeutics|July 18, 2019
A review and update on the diagnosis and treatment of neuropsychiatric Wilson diseaseSean Cleymaet, Katsuko Nagayoshi, Edward Gettings, et al.
Expert Review of Neurotherapeutics|July 24, 2024
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorderJustin Faden, Camila Ramirez, Vanessa Martinez, et al.
Expert Opinion on Pharmacotherapy|November 30, 2020
Does antipsychotic combination therapy reduce the risk of hospitalization in schizophrenia?Justin Faden, Natasha Kiryankova-Dalseth, Ruby Barghini, et al.
Pharmacogenomics and Personalized Medicine|December 26, 2023
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining QuestionsPriyanka Kolli, Grace Kelley, Marianela Rosales, et al.
Expert Opinion on Investigational Drugs|May 29, 2023
Potassium channel modulators and schizophrenia: an overview of investigational drugsMeghan Musselman, Eric Huynh, Rachana Kelshikar, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Psychological Reports|September 2, 2011
Screening for attention-deficit/hyperactivity disorder in adult inpatients with psychiatric disordersGeetha Kumar, Justin Faden, Robert A Steer
Expert Opinion on Pharmacotherapy|August 15, 2023
Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorderJustin Faden, Joseph F Goldberg, Leslie Citrome
Clinical Neuropharmacology|September 15, 2015
Are Second-Generation Antipsychotics Useful in Tardive Dystonia?Narsimha Reddy Pinninti, Justin Faden, Adit Adityanjee
International Journal of Surgery Case Reports|December 4, 2012
Obesity as a defense mechanismJustin Faden, Douglas Leonard, John O'Reardon, et al.
Case Reports in Psychiatry|April 4, 2017
Delusional Disorder, Erotomanic Type, Exacerbated by Social Media UseJustin Faden, Jonathan Levin, Ronak Mistry, et al.
Expert Review of Neurotherapeutics|July 18, 2019
A review and update on the diagnosis and treatment of neuropsychiatric Wilson diseaseSean Cleymaet, Katsuko Nagayoshi, Edward Gettings, et al.
Expert Review of Neurotherapeutics|July 24, 2024
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorderJustin Faden, Camila Ramirez, Vanessa Martinez, et al.
Expert Opinion on Pharmacotherapy|November 30, 2020
Does antipsychotic combination therapy reduce the risk of hospitalization in schizophrenia?Justin Faden, Natasha Kiryankova-Dalseth, Ruby Barghini, et al.
Pharmacogenomics and Personalized Medicine|December 26, 2023
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining QuestionsPriyanka Kolli, Grace Kelley, Marianela Rosales, et al.
Expert Opinion on Investigational Drugs|May 29, 2023
Potassium channel modulators and schizophrenia: an overview of investigational drugsMeghan Musselman, Eric Huynh, Rachana Kelshikar, et al.
Pageof 4